10 Small Stocks with Mighty Gains

6. Sana Biotechnology, Inc. (NASDAQ:SANA)

Sana Biotechnology soared by 14.53 percent on Wednesday to finish at $4.02 apiece as investors loaded portfolios ahead of its business updates next week.

In a statement, Sana Biotechnology, Inc. (NASDAQ:SANA) said that its president and chief executive officer, Steve Harr, would present the company’s business overview and update at the Citi 2025 Global Healthcare Conference on Tuesday, December 2, as well as the 8^th Annual Evercore Healthcare Conference on Wednesday, December 3.

Investors will be closely watching out for updated outlooks, particularly for SC451 and SG293—its drug candidates for the treatment of diabetes, as well as B-Cell cancer and autoimmune diseases, respectively.

Earlier this month, Sana Biotechnology, Inc. (NASDAQ:SANA) said that it would prioritize its operations in the development of the two treatments.

Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company focused on creating and delivering engineered cells as medicines.

In the third quarter of the year, the company narrowed its net loss by 30 percent to $42.15 million from $59.92 million in the same period last year.

Total operating expenses also dwindled by 29.5 percent to $43.51 million from $61.76 million year-on-year.